(Q50555874)
Statements
Cost-effectiveness of dabigatran etexilate for stroke prevention in non-valvular atrial fibrillation. Applying RE-LY to clinical practice in Denmark. (English)
1 reference
Lars K Langkilde
1 reference
Mikael Bergholdt Asmussen
1 reference
Mikkel Overgaard
1 reference
22 March 2012
1 reference
15
1 reference
4
1 reference
695-703
1 reference